EUVIMEDEUVIMED entdecken
Crossref

The Effect of Food on the Absorption of Oral Ziprasidone

Jeffrey J. Miceli, PhD, Paul Glue, MD, PhD, Jeffrey Alderman, PhD, and Keith Wilner, PhD

Psychopharmacology Bulletin · 12.08.2025 · 40 (3) · 58-59

DOI: 10.64719/pb.4109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychopharmacology Bulletin, online erschienen am 12.08.2025. Verfasst von Jeffrey J. Miceli und 8 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Oral ziprasidone bioavailability is known to increase when taken with food. Two pharmacokinetic studies were conducted to quantify the impact of food on ziprasidone absorption in healthy volunteers. Study 1: An open-label, six-way crossover study investigated ziprasidone absorption in eight healthy men. Subjects received oral ziprasidone (20, 40, and 80 mg) either after an 8-hour fast or immediately following a US Food and Drug Administration (FDA) standard meal (50% fat). At each dose, the area under the serum concentration–time curve (AUC) was greater in the fed than in the fasting state (20 mg, +48%; 40 mg, +87%; 80 mg, +101%). Under fasting conditions, increases in AUC and maximum drug concentration (Cmax) were less than dose-proportional; under fed conditions, they were dose-proportional. Study 2: An open-label, randomized, three-way crossover study explored the impact of dietary fat on ziprasidone absorption in 14 healthy subjects. Subjects received ziprasidone (40 mg) under three conditions: fasting, with a high-fat meal (60% fat), and with a moderate-fat meal (30% fat). Relative to fasting, AUC and Cmax increased by 104% and 84% (60% fat meal), and by 79% and 98% (30% fat meal), respectively. There was no clear difference in bioavailability between the fed groups, suggesting that meal fat content is not a major determinant of absorption. Key Findings: Less pharmacokinetic variability was observed in the fed state, suggesting more consistent absorption of ziprasidone when taken with food.

Conclusion

Administration of ziprasidone with food is crucial to ensure optimal, reliable, dose-dependent bioavailability and, therefore, predictable symptom control and tolerability. Psychopharmacology Bulletin. 2007;40(3):58–68.

Zitieren

APA

Miceli, J. J., PhD, Glue, P., MD, PhD, Alderman, J., PhD, Wilner, A. K., & PhD (2025). The Effect of Food on the Absorption of Oral Ziprasidone. Psychopharmacology Bulletin, 40(3), 58-59. https://doi.org/10.64719/pb.4109

Vancouver

Miceli JJ, PhD, Glue P, MD, PhD, Alderman J, et al. The Effect of Food on the Absorption of Oral Ziprasidone. Psychopharmacology Bulletin. 2025;40(3):58-59. doi:10.64719/pb.4109

BibTeX
@article{Miceli2025,
  author = {Miceli, Jeffrey J. and PhD and Glue, Paul and MD and PhD and Alderman, Jeffrey and PhD and Wilner, and Keith and PhD},
  title = {The Effect of Food on the Absorption of Oral Ziprasidone},
  journal = {Psychopharmacology Bulletin},
  year = {2025},
  volume = {40},
  number = {3},
  pages = {58--59},
  doi = {10.64719/pb.4109}
}
Kostenlos starten →